The results of our study indicate a pro-tumour role for tumour-derived STAT1 expression in HNSCC based on its ability to enhance PD-L1-mediated immunosuppression and proliferation in both UM-SCC22A and CAL27 HNSCC cell lines. The gene discussed is STAT1; the disease is head and neck squamous cell carcinoma.